Catalyst Financial Partners LLC Vascular Biogenics Ltd. Transaction History

Catalyst Financial Partners LLC

  • $455 Billion
  • Q2 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 02, 2023
BUY
$0.15 - $0.27 $5,850 - $10,530
39,000 New
39,000 $8.97 Million

Others Institutions Holding VBLT

# of Institutions
2
Shares Held
416K
Call Options Held
0
Put Options Held
0
View Full List

About Vascular Biogenics Ltd.

VBLT Quotes by TradingView
  • Ticker VBLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,348,896
  • Description
  • Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...
More about VBLT
Track This Portfolio

Track Catalyst Financial Partners LLC Portfolio

Follow Catalyst Financial Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalyst Financial Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Catalyst Financial Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email